TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
SUZ

Suzano Papel e Celulose SA

Basic Materials · Paper & Paper Products

8.50$ +2.4% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Suzano Papel e Celulose SA (SUZ) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 167,851 million BRL. Tick rows to compare them in a chart.

All figures in millions of BRL.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SUZ
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
28,119 28,260 29,399 28,523 53,933 24,339 19,599 118,975 133,198 143,593 165,936 167,851
6,609 6,589 8,030 6,797 30,799 4,694 3,457 34,103 37,123 38,569 42,183 43,845
3,686 1,477 1,615 1,077 4,387 808 1,316 13,591 9,506 8,346 9,019 15,172
3,686 2,448 3,695 2,708 25,486 2,337 1,742 21,099 17,053 21,170 21,990 25,100
1,207 1,886 2,161 2,298 2,537 1,086 782 6,899 10,164 7,737 10,242 8,960
1,077 1,316 1,313 1,208 1,853 1,207 780 4,637 5,728 5,947 7,962 8,229
7,654 20,477 20,308 20,760 21,956 55,543 54,662 55,212 70,398 82,764 92,450 95,725
79 45 45 45 158 2,004 1,544 8,251 8,253 8,421 8,418 8,183
213 284 174 143 182 2,399 1,683 8,015 7,173 6,557 5,710 4,781
17,804 19,068 19,256 16,901 41,907 19,842 18,186 103,800 100,032 98,783 133,521 123,921
3,068 3,511 3,830 3,708 6,059 2,854 1,573 11,551 14,493 14,795 24,478 13,766
1,795 2,025 1,595 2,115 3,427 1,491 333 4,279 4,007 5,512 11,374 2,336
502 581 583 621 633 591 455 3,289 6,207 5,572 6,033 5,139
4,494 12,892 12,418 10,077 32,311 57,456 70,856 75,973 71,240 72,414 90,934 91,796
10,315 9,192 10,143 11,622 12,012 4,468 1,392 15,075 33,061 44,693 32,284 43,790
1,852 706 1,639 2,923 2,993 317 -756 3,928 24,208 35,376 12,979 20,199
1,090 1,088 1,090 1,094 1,095 1,349 1,349 1,350 1,331 1,298 1,265 1,240

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?